In contrast, higher expression levels of AL513165.1 (HR = 0.350, 95%CI = 0.217 − 0.565) and PTOV1-AS2 (HR = 0.602, 95%CI = 0.454 − 0.800) were significantly associated with better prognosis in PAAD. Here, PTOV1 is linked to pancreatic adenocarcinoma.